US FDA to expand leucovorin’s approved use, but not for autism, WaPo reports

March 10 (Reuters) – The U.S. Food and ​Drug Administration will ‌announce on Tuesday that it ​will expand ​approval for leucovorin, but ⁠only for ​a rare ​condition that some people with autism also ​have – not ​for autism itself, the ‌Washington ⁠Post reported, citing officials.

The approval is for ​cerebral ​folate ⁠deficiency (CFD), a genetic condition ​that can ​cause ⁠autism-like symptoms, the report said.